HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of adrenocorticotropic hormone efficacy between aetiologies of infantile spasms.

AbstractPURPOSE:
We aimed to study the efficacy of adrenocorticotropic hormone (ACTH) treatment on infantile spasms with different aetiologies. In particular, we were interested in patients with structural-acquired aetiology.
METHODS:
Patients with infantile spasms, who were treated with ACTH, were divided into three groups based on the aetiologies: unknown aetiology with normal development (unknown-normal), structural-acquired, and combined-congenital aetiologies that included genetic, metabolic, structural-congenital, or unknown aetiology with developmental delay.
RESULTS:
Of the 107 patients included (58 males, 49 females), 25 patients had unknown-normal aetiology [median age at onset 5 months, standard deviation (SD) 3.12, range 2-16 months]; 20 patients had structural-acquired aetiology (median age at onset 6.5 months, SD 3.85 months, range 4-17 months); and 62 patients had combined-congenital aetiologies (median age at onset 5 months, SD 2.73 months, range 2-16 months). The efficacy of ACTH was 64.0 %, 65 %, and 30.6 % in the unknown-normal aetiology, structural-acquired aetiology, and combined-congenital aetiologies, respectively (p < 0.01). Multivariate analysis showed a statistically significant higher efficacy in the unknown-normal aetiology [Odds ratio (OR) 4.63, 95 % confidence interval (CI) 1.60-13.30] and structural-acquired aetiology (OR 3.41, 95 % CI 1.01-11.50) compared to that in the combined-congenital aetiologies.
CONCLUSION:
Infantile spasms with structural-acquired aetiology had greater response to ACTH treatment than those with combined-congenital aetiologies. The efficacy of standard therapy of infantile spasms should be considered based on aetiology.
AuthorsAtsuro Daida, Shin-Ichiro Hamano, Kuniyoshi Hayashi, Hazuki Nonoyama, Satoru Ikemoto, Yuko Hirata, Ryuki Matsuura, Reiko Koichihara, Gaku Yamanaka, Kenjiro Kikuchi
JournalSeizure (Seizure) Vol. 85 Pg. 6-11 (Feb 2021) ISSN: 1532-2688 [Electronic] England
PMID33360040 (Publication Type: Journal Article)
CopyrightCopyright © 2020 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Anticonvulsants
  • Adrenocorticotropic Hormone
Topics
  • Adrenocorticotropic Hormone (therapeutic use)
  • Age of Onset
  • Anticonvulsants (therapeutic use)
  • Female
  • Humans
  • Infant
  • Male
  • Spasms, Infantile (drug therapy, etiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: